[ad_1]
Shares of multi-cloud application services provider F5 climbed after the company’s fiscal third-quarter earnings beat analyst expectations and it raised its full-year earnings guidance.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...